Douyu
Reaven's REAVE-Alations Live Tarot readings.
Launch date
Employees
Market cap
$246m
Enterprise valuation
($600m) (Public information from Sep 2024)
Share price
$8.32 DOYU
Wuhan Hubei (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 9.6b | 9.2b | 7.1b | 5.5b | 4.4b | 4.3b | 4.3b |
| % growth | 32 % | (5 %) | (22 %) | (22 %) | (21 %) | (1 %) | - |
| EBITDA | 239m | (649m) | (199m) | (39.4m) | (581m) | (301m) | (145m) |
| % EBITDA margin | 2 % | (7 %) | (3 %) | (1 %) | (13 %) | (7 %) | (3 %) |
| Profit | 485m | (505m) | (75.4m) | 35.5m | 118m | 151m | - |
| % profit margin | 5 % | (6 %) | (1 %) | 1 % | 3 % | 4 % | - |
| EV / revenue | 1.6x | -0.1x | -0.5x | -0.7x | 0.2x | 0.2x | 0.3x |
| EV / EBITDA | 65.8x | 1.7x | 17.5x | 101.6x | -1.7x | -3.4x | -7.4x |
| R&D budget | 416m | 490m | 383m | 277m | - | - | - |
| R&D % of revenue | 4 % | 5 % | 5 % | 5 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$20.0m | Series A | ||
$100m Valuation: $1.0b | Series B | ||
$217m | Series C | ||
$145m Valuation: $1.3b | Series D | ||
$578m Valuation: $2.4b 8.6x EV/LTM Revenues -27.3x EV/LTM EBITDA | Series E | ||
| N/A | $775m Valuation: $4.0b 7.2x EV/LTM Revenues -32.5x EV/LTM EBITDA | IPO | |
| Total Funding | $1.1b | ||
